Elena Wadden, Vidhushei Yogeswaran, Roberta M Ray, Alexi Vasbinder, Aladdin H Shadyab, Qian Xiao, Phyllis A Richey, Nazmus Saquib, Yangbo Sun, Su Yon Jung, Margaret S Pichardo, JoAnn E Manson, Garnet Anderson, Michael Simon, Marcia L Stefanick, Kerryn Reding, Ana Barac, Richard K Cheng
{"title":"Social determinants of cardiovascular disease in women with and without breast cancer.","authors":"Elena Wadden, Vidhushei Yogeswaran, Roberta M Ray, Alexi Vasbinder, Aladdin H Shadyab, Qian Xiao, Phyllis A Richey, Nazmus Saquib, Yangbo Sun, Su Yon Jung, Margaret S Pichardo, JoAnn E Manson, Garnet Anderson, Michael Simon, Marcia L Stefanick, Kerryn Reding, Ana Barac, Richard K Cheng","doi":"10.1007/s10549-025-07731-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Social determinants of health (SDOH) may impact cardiovascular (CV) risk in women with and without breast cancer (BC).</p><p><strong>Methods: </strong>In 153,401 participants without prevalent CV disease from the Women's Health initiative (WHI), we assessed key SDOH factors: geographic region, rurality, insurance status, and household income. Multivariable Cox proportional hazards models were used to assess associations between SDOH factors and a composite CV outcome, which included incident myocardial infarction, incident stroke, hospitalization for heart failure, or CV death.</p><p><strong>Results: </strong>In the final cohort, 10,954 (mean ± standard deviation [SD] age 62 ± 7 years) women developed BC, and 142,144 (mean age 63 ± 7 years) women remained free of BC. During a median follow-up time of 13 years, 18,148 women experienced the composite CV outcome. Rurality, low household income, and non-private insurance were associated with an increased risk of the composite CV outcome and CV death, both in women with and without BC.</p><p><strong>Conclusions: </strong>SDOH factors are associated with an increased risk of CV events among women, irrespective of BC status. These associations highlight the importance of socioeconomic factors across cardiovascular health outcomes.</p>","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":"371-386"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-025-07731-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Social determinants of health (SDOH) may impact cardiovascular (CV) risk in women with and without breast cancer (BC).
Methods: In 153,401 participants without prevalent CV disease from the Women's Health initiative (WHI), we assessed key SDOH factors: geographic region, rurality, insurance status, and household income. Multivariable Cox proportional hazards models were used to assess associations between SDOH factors and a composite CV outcome, which included incident myocardial infarction, incident stroke, hospitalization for heart failure, or CV death.
Results: In the final cohort, 10,954 (mean ± standard deviation [SD] age 62 ± 7 years) women developed BC, and 142,144 (mean age 63 ± 7 years) women remained free of BC. During a median follow-up time of 13 years, 18,148 women experienced the composite CV outcome. Rurality, low household income, and non-private insurance were associated with an increased risk of the composite CV outcome and CV death, both in women with and without BC.
Conclusions: SDOH factors are associated with an increased risk of CV events among women, irrespective of BC status. These associations highlight the importance of socioeconomic factors across cardiovascular health outcomes.
期刊介绍:
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.